How can physicians and their patients with ALS decide to use the newly-available treatments to slow disease progression?

Carmel Armon

Research output: Contribution to journal › Review article › peer-review

Fingerprint

Dive into the research topics of 'How can physicians and their patients with ALS decide to use the newly-available treatments to slow disease progression?'. Together they form a unique fingerprint.

Medicine & Life Sciences